TAVR may be recommended as an alternative to traditional aortic valve replacement through open-heart surgery. It is particularly beneficial for older adults, those with additional serious health concerns, or individuals whose bodies may not recover well from major surgery. Recently, TAVR has also been successfully performed in patients at intermediate or low surgical risk, depending on their overall health and heart anatomy.
The primary objectives of TAVR are to alleviate your symptoms, enhance your quality of life, and enable you to resume activities you enjoy with fewer limitations.
While TAVR is less invasive than surgery, it remains a significant heart procedure with associated risks. Your heart team will discuss your specific risk factors and strategies to minimize them. They will also address your questions, ensuring you are well-informed and confident in your decision.
The TAVR team at Tanner Heart Care comprises (l-r) Joseph Massey, NP, structural heart coordinator; Hakob Davtyan, MD, cardiothoracic surgeon; Shazib Khawaja, MD, interventional cardiologist; Isida Byku, MD, structural heart proctor, Emory Healthcare; Chris Arant, MD, interventional cardiologist and Omar Lattouf, MD, cardiothoracic surgeon.